@Docace911 Profile picture

Docace911

@Docace911

Steven J Chmura MD PhD. Xbox aficionados and oncologist studying #ADscopal and #ABscopal along with #oligometastases., @Halo Infinite Rank Gold2

Similar User
Puneeth Iyengar photo

@IyengarPuneeth

Dan Trifiletti, MD photo

@DanTrifMD

Cliff Robinson photo

@SBRT_CR

Evan Thomas MD/PhD photo

@EvanThomas84

William A Hall, MD photo

@whallradonc

Sean Sachdev, MD photo

@SeanSachdevMD

Ann Klopp photo

@AnnKloppMD

Ralph Weichselbaum photo

@rweichselbaum

Elaine M. Zeman, PhD photo

@DrZeman

Bill Loo MD PhD ⚡️☢️ photo

@BLoo_LT_SABR

Jeff Bradley, MD photo

@JeffBradleyMD

Bradley Stish photo

@DrStish

Matt M photo

@drmattmc

Mohammad K. Khan, MD photo

@MohammadKhanMD

Dr. Loren K. Mell photo

@drlorenmell

Congrats!!!!!!!!!!!!!!!!!!!!!!!!!

Congrats to Dr. Kelli Pointer, our first Holman graduate, on her grant and continued success as a physician scientist! #RadOnc #GME #btsm



Docace911 Reposted

Happy to present our work led by excellent PGY4 @ConnorLynchMD on a pooled analysis of liver SBRT and immunotherapy in patients with polymetastatic disease treated on three phase 1 trials @UCCancerCenter redjournal.org/article/S0360-…  We show that:

Tweet Image 1

Docace911 Reposted
Tweet Image 1

Docace911 Reposted

In our #AskAScientist series on promising areas of cancer research for those starting their scientific careers, Ludwig @UChicagoMed’s Ralph Weichselbaum highlights bioinformatic analysis as a key skill for future researchers.

Tweet Image 1

Docace911 Reposted

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy - ScienceDirect Congrats ⁦@rweichselbaum⁩ ⁦@Docace911⁩ and team!! #radonc sciencedirect.com/science/articl…


Docace911 Reposted

Wonderful night celebrating our talented residents at our end of year graduation dinner. Looking forward to following the careers of a truly amazing class @jarah_md @RohanKatipally @grozomah @UChicagoRadonc

Tweet Image 1

Docace911 Reposted

Celebrating our wonderful clinical trial staff who make cutting edge research possible and accessible to our patients !! @UChicagoRadonc @UCCancerCenter @Docace911 @jarah_md @RohanKatipally

Tweet Image 1

Docace911 Reposted

There definitely is a bad scopal in some cases! Coming soon, May 25! This is great work however, when did parameters to see who will get immune stimulation or inhibitors


Docace911 Reposted

With @Docace911 we present our dogma challenging #RadOnc & #immunotherapy manuscript showing safety & prelim efficacy of partial tumor irradiation with anti-PD1. In contrast w aBscopal, we suggest an aDscopal effect where IO enhances local #radiation. jci.org/articles/view/…

Tweet Image 1

Docace911 Reposted

One day we will learn that overworking people is not beneficial. We will fix being short-staffed before it becomes an unsustainable problem. Until then, my vacation is worth gold.

In toxic cultures, you have to burn out to earn a break. Time off is how you recover. In decent cultures, you take a break when you're low on gas. Time off is how you refuel. In healthy cultures, you're expected to take regular breaks. Time off is encouraged to sustain energy.

Tweet Image 1


Docace911 Reposted

Just tested out #ChatGPT’s ability to write a letter to an insurance company with citations supporting RT for oligomets. It took ~ten seconds 🤯 #radonc

Tweet Image 1
Tweet Image 2

Docace911 Reposted

Dr. Julia White will discuss the NRG-BR007 DEBRA Trial today during a poster presentation at #SABCS22. This #clinicaltrial is looking at reducing the use of breast radiation after lumpectomy for people with low-risk, early-stage #breastcancer. Learn more: nrgoncology.org/DEBRA-Trial

Tweet Image 1

Docace911 Reposted

📢Excited that our new IIT evaluating ctDNA response-adaptive IO-based therapy in #headandneckcancer now open to accrual @UCCancerCenter! Thank you to @CancerRF for the support! 🧑‍🔬🔬clinicaltrials.gov/ct2/show/NCT05…


Docace911 Reposted

Two fantastic papers published this week in @NatureCancer & @NatureGenet by @SeanPitroda and his team. This work demonstrates the need for concurrent radiation and immunotherapy for certain mNSCLC patients. @UChicagoMed @UCCancerCenter @lfspurr ow.ly/qQTf50LRwKU

Tweet Image 1

Remember the NULL: fun to respond to this commentary with my good colleague @Dr_Julia_White and in my role as Hand to the King @IBCradiation @NRGonc @UChicagoBreast Reply to J. Widder ascopubs.org/doi/full/10.12…


Docace911 Reposted

📣 OUT NOW @NatureGenet 📰 Tumor aneuploidy predicts survival following immunotherapy across multiple cancers 🧑🏿‍🤝‍🧑🏽 @SeanPitroda and team 👇🏽 go.nature.com/3gLfoSk


Docace911 Reposted

I am pleased to share our recent work published in @NatureCancer: nature.com/articles/s4301…


Loading...

Something went wrong.


Something went wrong.